Kronos BioInc Correlations

KRON Stock  USD 1.00  0.02  1.96%   
The correlation of Kronos BioInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kronos BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kronos BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Significant diversification

The correlation between Kronos BioInc and NYA is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Kronos BioInc and NYA in the same portfolio, assuming nothing else is changed.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kronos BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Kronos Stock, please use our How to Invest in Kronos BioInc guide.
  
The ability to find closely correlated positions to Kronos BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kronos BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kronos BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kronos BioInc to buy it.

Moving together with Kronos Stock

  0.7EQ EquilliumPairCorr
  0.68VCNX VaccinexPairCorr
  0.62VERV Verve TherapeuticsPairCorr
  0.71DRTS Alpha Tau Medical Financial Report 28th of May 2024 PairCorr

Moving against Kronos Stock

  0.7VERU Veru Inc Fiscal Year End 13th of December 2024 PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
ACHLLRMR
REPLACHL
REPLSPRO
REPLLRMR
SPROACHL
SPRONXTC
  
High negative correlations   
ASMBACHL
ADXNLRMR
ASMBLRMR
ACHLADXN
CTMXADXN
REPLASMB

Risk-Adjusted Indicators

There is a big difference between Kronos Stock performing well and Kronos BioInc Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Kronos BioInc's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CYCN  3.90  0.00 (0.01) 0.04  4.57 
 9.75 
 24.49 
LRMR  3.28 (0.49) 0.00  0.46  0.00 
 6.05 
 17.62 
ADXN  5.20  0.43  0.03  6.56  10.42 
 16.39 
 80.86 
ACHL  3.39 (0.56) 0.00 (0.48) 0.00 
 8.40 
 34.56 
NXTC  4.65  0.25  0.05  0.25  5.44 
 13.10 
 32.48 
CTMX  8.79  3.31  0.23 (0.18) 8.02 
 10.00 
 266.04 
NLTX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SPRO  2.25  0.06 (0.01)(0.10) 2.88 
 4.82 
 16.04 
ASMB  2.38  0.46  0.13  0.72  2.95 
 5.32 
 17.67 
REPL  2.60 (0.67) 0.00 (0.41) 0.00 
 4.62 
 15.05 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Kronos BioInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Holdings Now

   

Portfolio Holdings

Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
All  Next Launch Module

Kronos BioInc Corporate Management

Elected by the shareholders, the Kronos BioInc's board of directors comprises two types of representatives: Kronos BioInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kronos. The board's role is to monitor Kronos BioInc's management team and ensure that shareholders' interests are well served. Kronos BioInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kronos BioInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher DinsmoreStrategic AdvisorProfile
Stephanie YaoExec CommunicationsProfile
Barbara JDStrategic AdvisorProfile
Marni KottleSr RelationsProfile
Rocio HoyosSenior ManagementProfile
Joshua KazamCoFounder DirectorProfile
Sandra GardinerInterim OfficerProfile

Already Invested in Kronos BioInc?

The danger of trading Kronos BioInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Kronos BioInc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Kronos BioInc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Kronos BioInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Kronos BioInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kronos BioInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kronos Bioinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kronos Bioinc Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kronos BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.
To learn how to invest in Kronos Stock, please use our How to Invest in Kronos BioInc guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Complementary Tools for Kronos Stock analysis

When running Kronos BioInc's price analysis, check to measure Kronos BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kronos BioInc is operating at the current time. Most of Kronos BioInc's value examination focuses on studying past and present price action to predict the probability of Kronos BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kronos BioInc's price. Additionally, you may evaluate how the addition of Kronos BioInc to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Is Kronos BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kronos BioInc. If investors know Kronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kronos BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Kronos BioInc is measured differently than its book value, which is the value of Kronos that is recorded on the company's balance sheet. Investors also form their own opinion of Kronos BioInc's value that differs from its market value or its book value, called intrinsic value, which is Kronos BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kronos BioInc's market value can be influenced by many factors that don't directly affect Kronos BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kronos BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kronos BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kronos BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.